Trial intelligence / Profile preview

Ropivacaine Wound Infiltration for Pain After Aortic Valve Surgery

NCT03079830Completed

Sponsor
University Medical Centre Ljubljana
Start
Oct 2016
Primary completion
Dec 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Cumulative postoperative dose of Piritramide at 48 hours. Started Oct 2016; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03079830.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03079830.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call